BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy782
(100 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1YIY|A Chain A, Aedes Aegypti Kynurenine Aminotransferase
pdb|1YIY|B Chain B, Aedes Aegypti Kynurenine Aminotransferase
pdb|2R5C|B Chain B, Aedes Kynurenine Aminotransferase In Complex With Cysteine
pdb|2R5E|A Chain A, Aedes Kynurenine Aminotransferase In Complex With
Glutamine
pdb|2R5E|B Chain B, Aedes Kynurenine Aminotransferase In Complex With
Glutamine
Length = 429
Score = 108 bits (271), Expect = 6e-25, Method: Composition-based stats.
Identities = 54/91 (59%), Positives = 68/91 (74%), Gaps = 1/91 (1%)
Query: 6 SKFALPPRFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLADAATGENKL 65
+KF LP R++ S SVWVE+IQL+ +KPLNLGQGFPDY AP + LA AA + L
Sbjct: 11 NKFDLPKRYQGSTKSVWVEYIQLAAQYKPLNLGQGFPDYH-APKYALNALAAAANSPDPL 69
Query: 66 LNQYTRGFGHPRIVQAIAKLYSSLIERPLLP 96
NQYTRGFGHPR+VQA++KLYS L++R + P
Sbjct: 70 ANQYTRGFGHPRLVQALSKLYSQLVDRTINP 100
>pdb|1YIZ|A Chain A, Aedes Aegypti Kynurenine Aminotrasferase
pdb|1YIZ|B Chain B, Aedes Aegypti Kynurenine Aminotrasferase
pdb|2R5C|A Chain A, Aedes Kynurenine Aminotransferase In Complex With Cysteine
Length = 429
Score = 108 bits (271), Expect = 6e-25, Method: Composition-based stats.
Identities = 54/91 (59%), Positives = 68/91 (74%), Gaps = 1/91 (1%)
Query: 6 SKFALPPRFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLADAATGENKL 65
+KF LP R++ S SVWVE+IQL+ +KPLNLGQGFPDY AP + LA AA + L
Sbjct: 11 NKFDLPKRYQGSTKSVWVEYIQLAAQYKPLNLGQGFPDYH-APKYALNALAAAANSPDPL 69
Query: 66 LNQYTRGFGHPRIVQAIAKLYSSLIERPLLP 96
NQYTRGFGHPR+VQA++KLYS L++R + P
Sbjct: 70 ANQYTRGFGHPRLVQALSKLYSQLVDRTINP 100
>pdb|3E2Z|B Chain B, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii In Complex With Kynurenine
pdb|3E2Y|A Chain A, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii In Complex With Glutamine
pdb|3E2Y|B Chain B, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii In Complex With Glutamine
Length = 410
Score = 80.1 bits (196), Expect = 3e-16, Method: Composition-based stats.
Identities = 41/86 (47%), Positives = 59/86 (68%), Gaps = 3/86 (3%)
Query: 13 RFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLADAATGENKLLNQYTRG 72
R E +VWVEF +L+ D +NLGQGFPD S PS+V + L+ AA +N +NQYTRG
Sbjct: 4 RIEGLDSNVWVEFTKLAADPSVVNLGQGFPDI-SPPSYVKEELSKAAFIDN--MNQYTRG 60
Query: 73 FGHPRIVQAIAKLYSSLIERPLLPHQ 98
FGHP +V+A++ LY + +R + P++
Sbjct: 61 FGHPALVKALSCLYGKIYQRQIDPNE 86
>pdb|3E2F|A Chain A, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii, Plp-Bound Form
pdb|3E2F|B Chain B, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii, Plp-Bound Form
pdb|3E2Z|A Chain A, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii In Complex With Kynurenine
pdb|2ZJG|A Chain A, Crystal Structural Of Mouse Kynurenine Aminotransferase
Iii
pdb|2ZJG|B Chain B, Crystal Structural Of Mouse Kynurenine Aminotransferase
Iii
Length = 410
Score = 80.1 bits (196), Expect = 3e-16, Method: Composition-based stats.
Identities = 41/86 (47%), Positives = 59/86 (68%), Gaps = 3/86 (3%)
Query: 13 RFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLADAATGENKLLNQYTRG 72
R E +VWVEF +L+ D +NLGQGFPD S PS+V + L+ AA +N +NQYTRG
Sbjct: 4 RIEGLDSNVWVEFTKLAADPSVVNLGQGFPDI-SPPSYVKEELSKAAFIDN--MNQYTRG 60
Query: 73 FGHPRIVQAIAKLYSSLIERPLLPHQ 98
FGHP +V+A++ LY + +R + P++
Sbjct: 61 FGHPALVKALSCLYGKIYQRQIDPNE 86
>pdb|1W7N|A Chain A, Crystal Structure Of Human Kynurenine Aminotransferase I
In Pmp Form
Length = 422
Score = 63.9 bits (154), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 51/84 (60%), Gaps = 2/84 (2%)
Query: 13 RFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLADAATGENKLLNQYTRG 72
R + Y+ WVEF++L+ +H +NLGQGFPD+ P + A +G+ +LNQYT+
Sbjct: 9 RLDGIDYNPWVEFVKLASEHDVVNLGQGFPDF-PPPDFAVEAFQHAVSGDF-MLNQYTKT 66
Query: 73 FGHPRIVQAIAKLYSSLIERPLLP 96
FG+P + + +A + L+ + + P
Sbjct: 67 FGYPPLTKILASFFGELLGQEIDP 90
>pdb|3FVS|A Chain A, Human Kynurenine Aminotransferase I In Complex With
Glycerol
pdb|3FVS|B Chain B, Human Kynurenine Aminotransferase I In Complex With
Glycerol
pdb|3FVU|A Chain A, Crystal Structure Of Human Kynurenine Aminotransferase I
In Complex With Indole-3-acetic Acid
pdb|3FVU|B Chain B, Crystal Structure Of Human Kynurenine Aminotransferase I
In Complex With Indole-3-acetic Acid
pdb|3FVX|A Chain A, Human Kynurenine Aminotransferase I In Complex With Tris
pdb|3FVX|B Chain B, Human Kynurenine Aminotransferase I In Complex With Tris
Length = 422
Score = 63.9 bits (154), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 51/84 (60%), Gaps = 2/84 (2%)
Query: 13 RFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLADAATGENKLLNQYTRG 72
R + Y+ WVEF++L+ +H +NLGQGFPD+ P + A +G+ +LNQYT+
Sbjct: 9 RLDGIDYNPWVEFVKLASEHDVVNLGQGFPDF-PPPDFAVEAFQHAVSGDF-MLNQYTKT 66
Query: 73 FGHPRIVQAIAKLYSSLIERPLLP 96
FG+P + + +A + L+ + + P
Sbjct: 67 FGYPPLTKILASFFGELLGQEIDP 90
>pdb|1W7L|A Chain A, Crystal Structure Of Human Kynurenine Aminotransferase I
pdb|1W7M|A Chain A, Crystal Structure Of Human Kynurenine Aminotransferase I
In Complex With L-Phe
Length = 422
Score = 63.9 bits (154), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 51/84 (60%), Gaps = 2/84 (2%)
Query: 13 RFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLADAATGENKLLNQYTRG 72
R + Y+ WVEF++L+ +H +NLGQGFPD+ P + A +G+ +LNQYT+
Sbjct: 9 RLDGIDYNPWVEFVKLASEHDVVNLGQGFPDF-PPPDFAVEAFQHAVSGDF-MLNQYTKT 66
Query: 73 FGHPRIVQAIAKLYSSLIERPLLP 96
FG+P + + +A + L+ + + P
Sbjct: 67 FGYPPLTKILASFFGELLGQEIDP 90
>pdb|2Y7T|A Chain A, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|B Chain B, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|C Chain C, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|D Chain D, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|E Chain E, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|F Chain F, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|G Chain G, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|H Chain H, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|I Chain I, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|J Chain J, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|K Chain K, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|L Chain L, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|M Chain M, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|N Chain N, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|O Chain O, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|P Chain P, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|Q Chain Q, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|R Chain R, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|S Chain S, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7T|T Chain T, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|A Chain A, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|B Chain B, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|C Chain C, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|D Chain D, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|E Chain E, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|F Chain F, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|G Chain G, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|H Chain H, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|I Chain I, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|J Chain J, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|K Chain K, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|L Chain L, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|M Chain M, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|N Chain N, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|O Chain O, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|P Chain P, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|Q Chain Q, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|R Chain R, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|S Chain S, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7U|T Chain T, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|A Chain A, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|B Chain B, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|C Chain C, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|D Chain D, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|E Chain E, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|F Chain F, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|G Chain G, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|H Chain H, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|I Chain I, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|J Chain J, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|K Chain K, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|L Chain L, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|M Chain M, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|N Chain N, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|O Chain O, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|P Chain P, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|Q Chain Q, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|R Chain R, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|S Chain S, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2Y7V|T Chain T, X-Ray Structure Of The Grapevine Fanleaf Virus
pdb|2YI2|A Chain A, Grapevine Fanleaf Virus
pdb|2YI2|B Chain B, Grapevine Fanleaf Virus
pdb|2YI2|C Chain C, Grapevine Fanleaf Virus
pdb|2YI2|D Chain D, Grapevine Fanleaf Virus
pdb|2YI2|E Chain E, Grapevine Fanleaf Virus
pdb|2YI2|F Chain F, Grapevine Fanleaf Virus
pdb|2YI2|G Chain G, Grapevine Fanleaf Virus
pdb|2YI2|H Chain H, Grapevine Fanleaf Virus
pdb|2YI2|I Chain I, Grapevine Fanleaf Virus
pdb|2YI2|J Chain J, Grapevine Fanleaf Virus
pdb|2YI2|K Chain K, Grapevine Fanleaf Virus
pdb|2YI2|L Chain L, Grapevine Fanleaf Virus
pdb|2YI2|M Chain M, Grapevine Fanleaf Virus
pdb|2YI2|N Chain N, Grapevine Fanleaf Virus
pdb|2YI2|O Chain O, Grapevine Fanleaf Virus
pdb|2YI2|P Chain P, Grapevine Fanleaf Virus
pdb|2YI2|Q Chain Q, Grapevine Fanleaf Virus
pdb|2YI2|R Chain R, Grapevine Fanleaf Virus
pdb|2YI2|S Chain S, Grapevine Fanleaf Virus
pdb|2YI2|T Chain T, Grapevine Fanleaf Virus
pdb|2YI3|A Chain A, Grapevine Fanleaf Virus
pdb|2YI3|B Chain B, Grapevine Fanleaf Virus
pdb|2YI3|C Chain C, Grapevine Fanleaf Virus
pdb|2YI3|D Chain D, Grapevine Fanleaf Virus
pdb|2YI3|E Chain E, Grapevine Fanleaf Virus
pdb|2YI3|F Chain F, Grapevine Fanleaf Virus
pdb|2YI3|G Chain G, Grapevine Fanleaf Virus
pdb|2YI3|H Chain H, Grapevine Fanleaf Virus
pdb|2YI3|I Chain I, Grapevine Fanleaf Virus
pdb|2YI3|J Chain J, Grapevine Fanleaf Virus
pdb|2YI3|K Chain K, Grapevine Fanleaf Virus
pdb|2YI3|L Chain L, Grapevine Fanleaf Virus
pdb|2YI3|M Chain M, Grapevine Fanleaf Virus
pdb|2YI3|N Chain N, Grapevine Fanleaf Virus
pdb|2YI3|O Chain O, Grapevine Fanleaf Virus
pdb|2YI3|P Chain P, Grapevine Fanleaf Virus
pdb|2YI3|Q Chain Q, Grapevine Fanleaf Virus
pdb|2YI3|R Chain R, Grapevine Fanleaf Virus
pdb|2YI3|S Chain S, Grapevine Fanleaf Virus
pdb|2YI3|T Chain T, Grapevine Fanleaf Virus
pdb|2YI4|A Chain A, Grapevine Fanleaf Virus
pdb|2YI4|B Chain B, Grapevine Fanleaf Virus
pdb|2YI4|C Chain C, Grapevine Fanleaf Virus
pdb|2YI4|D Chain D, Grapevine Fanleaf Virus
pdb|2YI4|E Chain E, Grapevine Fanleaf Virus
pdb|2YI4|F Chain F, Grapevine Fanleaf Virus
pdb|2YI4|G Chain G, Grapevine Fanleaf Virus
pdb|2YI4|H Chain H, Grapevine Fanleaf Virus
pdb|2YI4|I Chain I, Grapevine Fanleaf Virus
pdb|2YI4|J Chain J, Grapevine Fanleaf Virus
pdb|2YI4|K Chain K, Grapevine Fanleaf Virus
pdb|2YI4|L Chain L, Grapevine Fanleaf Virus
pdb|2YI4|M Chain M, Grapevine Fanleaf Virus
pdb|2YI4|N Chain N, Grapevine Fanleaf Virus
pdb|2YI4|O Chain O, Grapevine Fanleaf Virus
pdb|2YI4|P Chain P, Grapevine Fanleaf Virus
pdb|2YI4|Q Chain Q, Grapevine Fanleaf Virus
pdb|2YI4|R Chain R, Grapevine Fanleaf Virus
pdb|2YI4|S Chain S, Grapevine Fanleaf Virus
pdb|2YI4|T Chain T, Grapevine Fanleaf Virus
Length = 504
Score = 34.7 bits (78), Expect = 0.016, Method: Composition-based stats.
Identities = 17/43 (39%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 12 PRFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKG 54
P FE Y VWV+F + +LD + + +G F D+ S VS G
Sbjct: 341 PSFEDD-YFVWVDFSEFTLDKEEIEIGSRFFDFTSNTCRVSMG 382
>pdb|2Y26|A Chain A, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|B Chain B, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|C Chain C, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|D Chain D, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|E Chain E, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|F Chain F, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|G Chain G, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|H Chain H, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|I Chain I, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|J Chain J, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|K Chain K, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|L Chain L, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|M Chain M, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|N Chain N, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|O Chain O, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|P Chain P, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|Q Chain Q, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|R Chain R, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|S Chain S, Transmission Defective Mutant Of Grapevine Fanleaf Virus
pdb|2Y26|T Chain T, Transmission Defective Mutant Of Grapevine Fanleaf Virus
Length = 504
Score = 34.3 bits (77), Expect = 0.016, Method: Composition-based stats.
Identities = 17/43 (39%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 12 PRFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKG 54
P FE Y VWV+F + +LD + + +G F D+ S VS G
Sbjct: 341 PSFEDD-YFVWVDFSEFTLDKEEIEIGSRFFDFTSNTCRVSMG 382
>pdb|3B46|A Chain A, Crystal Structure Of Bna3p, A Putative Kynurenine
Aminotransferase From Saccharomyces Cerevisiae
pdb|3B46|B Chain B, Crystal Structure Of Bna3p, A Putative Kynurenine
Aminotransferase From Saccharomyces Cerevisiae
Length = 447
Score = 33.5 bits (75), Expect = 0.034, Method: Composition-based stats.
Identities = 20/55 (36%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 35 LNLGQGFPDYESAPSHVSKGLADAATGENKLLNQYTRGFGHPRIVQAIAKLYSSL 89
+NLGQGF Y S P K A + ++NQY+ G P ++ ++ KLYS +
Sbjct: 60 INLGQGFFSY-SPPQFAIKEAQKAL--DIPMVNQYSPTRGRPSLINSLIKLYSPI 111
>pdb|2O0R|A Chain A, The Three-Dimensional Structure Of
N-Succinyldiaminopimelate Aminotransferase From
Mycobacterium Tuberculosis
pdb|2O0R|B Chain B, The Three-Dimensional Structure Of
N-Succinyldiaminopimelate Aminotransferase From
Mycobacterium Tuberculosis
Length = 411
Score = 32.0 bits (71), Expect = 0.083, Method: Composition-based stats.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 13 RFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLADAATGENKLLNQYTRG 72
R +V+ E L+ +NLGQGFPD E P + + DA G +NQY G
Sbjct: 6 RLRPYATTVFAEMSALATRIGAVNLGQGFPD-EDGPPKMLQAAQDAIAGG---VNQYPPG 61
Query: 73 FG 74
G
Sbjct: 62 PG 63
>pdb|1U08|A Chain A, Crystal Structure And Reactivity Of Ybdl From
Escherichia Coli Identify A Methionine Aminotransferase
Function.
pdb|1U08|B Chain B, Crystal Structure And Reactivity Of Ybdl From
Escherichia Coli Identify A Methionine Aminotransferase
Function
Length = 386
Score = 31.6 bits (70), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 21/66 (31%), Positives = 36/66 (54%), Gaps = 6/66 (9%)
Query: 20 SVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLA-DAATGENKLLNQYTRGFGHPRI 78
+++ + L+ H+ +NL QGFPD++ P ++ + LA A G NQY G +
Sbjct: 18 TIFTQMSALAQQHQAINLSQGFPDFD-GPRYLQERLAHHVAQGA----NQYAPMTGVQAL 72
Query: 79 VQAIAK 84
+AIA+
Sbjct: 73 REAIAQ 78
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 27.7 bits (60), Expect = 1.8, Method: Composition-based stats.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 5/56 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPL 94
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 156 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPV 208
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 27.7 bits (60), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 27.7 bits (60), Expect = 1.9, Method: Composition-based stats.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 5/56 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPL 94
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 169 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPV 221
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 27.7 bits (60), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 27.3 bits (59), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 27.3 bits (59), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 27.3 bits (59), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 5/56 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPL 94
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 285 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPV 337
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 121 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 174
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 152 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 205
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 149 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 202
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 150 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 203
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 150 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 203
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 150 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 203
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 151 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 204
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 27.3 bits (59), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 156 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 209
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 27.3 bits (59), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 150 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 203
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 27.3 bits (59), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 152 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 205
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 27.3 bits (59), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 124 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVN---LPIVERPVC 177
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 26.6 bits (57), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 41 FPDYESAPSHVSKGLADAATGENKLLNQYTR--GFGHPRIVQAIAKLYSSLIERPLL 95
PD E+A S + G TG L +T G G P ++Q + ++ERP+
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQPSVLQVVN---LPIVERPVC 173
>pdb|1V2D|A Chain A, Crystal Structure Of T.Th Hb8 Glutamine Aminotransferase
pdb|1V2E|A Chain A, Crystal Structure Of T.Th Hb8 Glutamine Aminotransferase
Complex With A-Keto-G-Methylthiobutyrate
pdb|1V2E|B Chain B, Crystal Structure Of T.Th Hb8 Glutamine Aminotransferase
Complex With A-Keto-G-Methylthiobutyrate
pdb|1V2F|A Chain A, Crystal Structure Of T.Th Hb8 Glutamine Aminotransferase
Complex With 3-Phenylpropionate
pdb|1V2F|B Chain B, Crystal Structure Of T.Th Hb8 Glutamine Aminotransferase
Complex With 3-Phenylpropionate
Length = 381
Score = 26.6 bits (57), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 22/76 (28%), Positives = 35/76 (46%), Gaps = 5/76 (6%)
Query: 12 PRFEASVYSVWVEFIQLSLDHKPLNLGQGFPDYESAPSHVSKGLADAATGENKLLNQYTR 71
PR EA+ S++ L+ +NLGQGFP P L +A +QY
Sbjct: 5 PRTEAAKESIFPRMSGLAQRLGAVNLGQGFPSNPPPPF-----LLEAVRRALGRQDQYAP 59
Query: 72 GFGHPRIVQAIAKLYS 87
G P + +A+A+ ++
Sbjct: 60 PAGLPALREALAEEFA 75
>pdb|3RYT|A Chain A, The Plexin A1 Intracellular Region In Complex With Rac1
pdb|3RYT|B Chain B, The Plexin A1 Intracellular Region In Complex With Rac1
Length = 626
Score = 25.8 bits (55), Expect = 6.2, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 28/51 (54%), Gaps = 2/51 (3%)
Query: 24 EFIQLSLDHKPLNLGQGFPDYESAPSHVSKGL-ADAATG-ENKLLNQYTRG 72
+ I+ +D+K L L P++E+AP KGL D T + KLL+ +G
Sbjct: 222 KLIRQQIDYKTLTLNCVNPEHENAPEVPVKGLNCDTVTQVKEKLLDAVYKG 272
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.134 0.395
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 3,006,105
Number of Sequences: 62578
Number of extensions: 106839
Number of successful extensions: 258
Number of sequences better than 100.0: 50
Number of HSP's better than 100.0 without gapping: 13
Number of HSP's successfully gapped in prelim test: 37
Number of HSP's that attempted gapping in prelim test: 238
Number of HSP's gapped (non-prelim): 50
length of query: 100
length of database: 14,973,337
effective HSP length: 66
effective length of query: 34
effective length of database: 10,843,189
effective search space: 368668426
effective search space used: 368668426
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 45 (21.9 bits)